| Date | Title | Description | |
|---|---|---|---|
| 17 Dec 2021 | On business and financial situation | ROVI reports that the CHMP has issued a positive opinion on Okedi® for the treatment for schizophrenia | Download |
| 13 Dec 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 6 December 2021 and 10 December 2021 | Download |
| 06 Dec 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 29 November 2021 and 3 December 2021 | Download |
| 22 Nov 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 15 November 2021 and 19 November 2021 | Download |
| 16 Nov 2021 | Liquidity and counterparty agreements | The Company informs of the termination of the Liquidity Agreement | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 28 Jul 2016 | Información sobre resultados (2) | ROVI releases the press release related to the 2016 first half results | Download |
| 28 Jul 2016 | Información sobre resultados | ROVI releases the presentation related to the 2016 first half results | Download |
| 05 Jul 2016 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the second quarter of 2016 | Download |
| 24 Jun 2016 | Información sobre dividendos | The Company informs about the dividends payment | Download |
| 31 May 2016 | Convocatorias y acuerdos de Juntas y Asambleas generales | ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting | Download |